Encevac TC-4 + VEE with HavlogenThis page contains information on Encevac TC-4 + VEE with Havlogen for veterinary use.
The information provided typically includes the following:
- Encevac TC-4 + VEE with Havlogen Indications
- Warnings and cautions for Encevac TC-4 + VEE with Havlogen
- Direction and dosage information for Encevac TC-4 + VEE with Havlogen
Encevac TC-4 + VEE with HavlogenThis treatment applies to the following species:
ENCEPHALOMYELITIS - INFLUENZA VACCINE, EASTERN & WESTERN & VENEZUELAN, KILLED VIRUS, TETANUS TOXOID
A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern, Western and Venezuelan), equine influenza virus type H3N8 strains (EIV A/Equine 2/Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American and EIV A/Equine 2/Newmarket/2/93 Eurasian) and tetanus toxoid. Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89 and South Africa 03.
Encevac TC-4 + VEE with Havlogen Indications
For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of disease caused by Eastern, Western and Venezuelan encephalomyelitis viruses and tetanus and as an aid in the control of respiratory disease and as an aid in the reduction of virus shedding caused by EIV. Duration of immunity (DOI) has been shown to be at least 6 months for EIV. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.
DOSE: For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.
CAUTIONS: Store at 2°-7°C (35°-45°F). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reaction may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactic reactions may occur. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.
Adjuvant: Intervet’s Proprietary Technology
FOR ANIMAL USE ONLY
Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, NE 68103, USA
U.S. Vet Lic. No 165A
1 800 521-5767 (USA)
1 866 683-7838 (CAN)
For patent information: http://www.merck.com/product/patent/home.html
NAC No.: 10473202
556 MORRIS AVE., SUMMIT, NJ, 07901
|Technical Service (Companion Animal):||800-224-5318|
|Technical Service (Livestock):||800-211-3573|
|Every effort has been made to ensure the accuracy of the Encevac TC-4 + VEE with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2013-12-23